1. Dyslipidemia and the Risk of Developing Hypertension in a Working-Age Male Population;Otsuka;J Am Hear Assoc Cardiovasc Cerebrovasc Dis,2016
2. Fimasartan Potassium Trihydrate | C27H36KN7O4S | CID 46929800 - PubChem n.d. https://pubchem.ncbi.nlm.nih.gov/compound/Fimasartan-Potassium-Trihydrate (accessed June 1, 2023).
3. Atorvastatin | C33H35FN2O5 CID 60823 - PubChem n.d. https://pubchem.ncbi.nlm.nih.gov/compound/Atorvastatin (accessed June 1, 2023).
4. A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia - Full Text View - ClinicalTrials.gov n.d. https://clinicaltrials.gov/ct2/show/NCT03338426 (accessed April 21, 2023).
5. Three different methods for determination of binary mixture of Amlodipine and Atorvastatin using dual wavelength spectrophotometry;Darwish;Spectrochim Acta Part A Mol Biomol Spectrosc,2013